Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/EFFECTOR-THERAPEUTICS-INC-119661016/nieuws/EFFECTOR-Therapeutics-Inc-Kondigt-tussentijdse-gegevens-aan-van-de-lopende-fase-1-2-klinische-stud-40570598/?utm_source=whatsapp&utm_medium=social&utm_campaign=share